CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 130 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,539 | +3891.4% | 45,509 | +708.6% | 0.00% | – |
| Q2 2022 | $17,000 | -26.1% | 5,628 | -22.4% | 0.00% | – |
| Q1 2022 | $23,000 | -8.0% | 7,256 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | +13.6% | 7,256 | +20.6% | 0.00% | – |
| Q3 2021 | $22,000 | -15.4% | 6,015 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -3.7% | 6,015 | 0.0% | 0.00% | – |
| Q1 2021 | $27,000 | +35.0% | 6,015 | +71.9% | 0.00% | – |
| Q4 2020 | $20,000 | -20.0% | 3,500 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |